Skip to main content

Advertisement

Log in

The triglycerides and glucose index is highly associated with non-alcoholic fatty liver disease in overweight and obese women

  • Original Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Background

Although some previous studies have indicated that the triglycerides and glucose (TyG) index is associated with an increased risk of non-alcoholic fatty liver disease (NAFLD), there are still few studies in this field.

Aims

The goal of this study was to assess whether the TyG index is associated with the presence of non-alcoholic fatty liver disease NAFLD in overweight and obese women.

Methods

Overweight and obese women aged 20 to 65 years were enrolled in a cross-sectional study and allocated into the groups with and without NAFLD. Alcohol consumption, pregnancy, normal-weight, positive markers of viral or autoimmune hepatitis, acute or chronic liver disease, renal disease, cardiovascular disease, neoplasia, and intake of hepatotoxic drugs were exclusion criteria. The diagnosis of NAFLD was established by liver ultrasound and the TyG index was calculated as the Ln [fasting triglycerides (mg/dL) × fasting glucose (mg/dL)]/2.

Results

A total of 420 participants were enrolled and allocated into the groups with (n = 212) and without (n = 208) NAFLD. In the overall population, the frequency of NAFLD was 50.4%. The logistic regression analysis adjusted by body mass index, waist circumference, and total body fat showed that total cholesterol (OR = 1.004; 95% CI: 1.000–1.007), triglycerides (OR = 1.002; 95% CI: 1.000–1.004), AST (OR = 1.19; 95% CI: 1.15–1.23), ALT (OR = 1.20; 95% CI: 1.15–1.25), and TyG index (OR = 3.15; 95% CI: 1.64–6.06) are significantly associated with NAFLD.

Conclusions

The results show that the TyG index is highly associated with the presence of NAFLD in women with overweight and obesity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Younossi ZM, Koenig AB, Abdelatif D et al (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64:73–84. https://doi.org/10.1002/hep.28431

    Article  PubMed  Google Scholar 

  2. Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274–285. https://doi.org/10.1111/j.1365-2036.2011.04724.x

    Article  CAS  PubMed  Google Scholar 

  3. Day CP, James OFW (1998) Steatohepatitis: a tale of two “hits”? Gastroenterology 114:842–845. https://doi.org/10.1016/S0016-5085(98)70599-2

    Article  CAS  PubMed  Google Scholar 

  4. Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495. https://doi.org/10.2337/diacare.27.6.1487

    Article  PubMed  Google Scholar 

  5. Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F (2008) The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 6:299–304. https://doi.org/10.1089/met.2008.0034

    Article  CAS  PubMed  Google Scholar 

  6. Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M et al (2010) The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab 95:3347–3351. https://doi.org/10.1210/jc.2010-0288

    Article  CAS  PubMed  Google Scholar 

  7. Liu J, Guan L, Zhao M et al (2021) Association between the triglyceride–glucose index and outcomes of nonalcoholic fatty liver disease: a large-scale health management cohort study. Diabetes, Metab Syndr Obes Targets Ther 14:2829–2839. https://doi.org/10.2147/DMSO.S316864

    Article  Google Scholar 

  8. Khamseh ME, Malek M, Abbasi R et al (2021) Triglyceride glucose index and related parameters (triglyceride glucose-body mass index and triglyceride glucose-waist circumference) identify nonalcoholic fatty liver and liver fibrosis in individuals with overweight/obesity. Metab Syndr Relat Disord 19:167–173. https://doi.org/10.1089/met.2020.0109

    Article  CAS  PubMed  Google Scholar 

  9. Liu YT, Wang W, Tong J, Wang BY (2021) Relationship between triglyceride-glucose index and non-alcoholic fatty liver disease. Zhonghua Gan Zang Bing Za Zhi 29:451–455. https://doi.org/10.3760/cma.j.cn501113-20200615-00322

    Article  CAS  PubMed  Google Scholar 

  10. Wang X, Zhou W, Song Q, Xie Y (2023) Association of the triglyceride-glucose index with the occurrence of non-alcoholic fatty liver disease and mortality in elderly inpatients: a prospective observational study. Nutr Hosp. https://doi.org/10.20960/NH.04435

  11. Nakao K, Nakata K, Ohtsubo N et al (2002) Association between nonalcoholic fatty liver, markers of obesity, and serum leptin level in young adults. Am J Gastroenterol 97:1796–1801. https://doi.org/10.1111/j.1572-0241.2002.05846.x

    Article  CAS  PubMed  Google Scholar 

  12. Hamaguchi M, Kojima T, Itoh Y et al (2007) The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 102:2708–2715. https://doi.org/10.1111/j.1572-0241.2007.01526.x

    Article  PubMed  Google Scholar 

  13. Hernaez R, Lazo M, Bonekamp S et al (2011) Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54:1082–1090. https://doi.org/10.1002/HEP.24452

    Article  PubMed  Google Scholar 

  14. Chobanian AV, Bakris GL, Black HR et al (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42:1206–1252. https://doi.org/10.1161/01.HYP.0000107251.49515.c2

    Article  CAS  PubMed  Google Scholar 

  15. Quek J, Chan KE, Wong ZY et al (2023) Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 8:20–30. https://doi.org/10.1016/S2468-1253(22)00317-X

  16. Lin I-T, Lee M-Y, Wang C-W et al (2021) Gender differences in the relationships among metabolic syndrome and various obesity-related indices with nonalcoholic fatty liver disease in a Taiwanese population. Int J Environ Res Public Health 18:857. https://doi.org/10.3390/ijerph18030857

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Lovejoy JC, Champagne CM, de Jonge L et al (2008) Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes 32:949–958. https://doi.org/10.1038/ijo.2008.25

    Article  CAS  Google Scholar 

  18. Clark JM, Brancati FL, Diehl AM (2002) Nonalcoholic fatty liver disease. Gastroenterology 122:1649–1657. https://doi.org/10.1053/gast.2002.33573

    Article  PubMed  Google Scholar 

  19. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846. https://doi.org/10.1038/nature05482

    Article  CAS  PubMed  Google Scholar 

  20. Mehta SR, Godsland IF, Thomas EL et al (2012) Intrahepatic insulin exposure, intrahepatocellular lipid and regional body fat in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 97:2151–2159. https://doi.org/10.1210/jc.2011-2430

    Article  CAS  PubMed  Google Scholar 

  21. Wang Z, Xu M, Hu Z, Shrestha UK (2015) Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index. Menopause 22:667–673. https://doi.org/10.1097/GME.0000000000000352

    Article  PubMed  Google Scholar 

  22. Lavoie J-M, Pighon A (2012) NAFLD, estrogens, and physical exercise: the animal model. J Nutr Metab 2012:1–13. https://doi.org/10.1155/2012/914938

    Article  CAS  Google Scholar 

  23. Saad F, Gooren LJ (2011) The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2. J Obes 2011:1–10. https://doi.org/10.1155/2011/471584

    Article  CAS  Google Scholar 

  24. Shifren JL (2009) Androgens, estrogens, and metabolic syndrome at midlife. Menopause 16:226–228. https://doi.org/10.1097/gme.0b013e3181974ffc

    Article  PubMed  Google Scholar 

  25. Zhang S, Du T, Zhang J et al (2017) The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis 16:15. https://doi.org/10.1186/s12944-017-0409-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Gastaldelli A, Folli FDR (2010) The product of triglycerides and glucose as index of insulin resistance. Validation in the SAM study. J Clin Endocrinol Metab 95:3351

  27. Matsuzawa N, Takamura T, Kurita S et al (2007) Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 46:1392–1403. https://doi.org/10.1002/hep.21874

    Article  CAS  PubMed  Google Scholar 

  28. Méndez-Sánchez N, Arrese M, Zamora-Valdés D, Uribe M (2007) Current concepts in the pathogenesis of nonalcoholic fatty liver disease. Liver Int 27:423–433. https://doi.org/10.1111/j.1478-3231.2007.01483.x

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

H. Rodríguez-Hernández and L. E. Simental-Mendía equally contributed to the conception and design of the research; H. Rodríguez-Hernández and L. E. Simental-Mendía contributed to the design of the research; H. Rodríguez-Hernández and L.E. Simental-Mendía contributed to the interpretation of the data; and H. Rodríguez-Hernández and L.E. Simental-Mendía drafted the manuscript. All authors critically revised the manuscript, agree to be fully accountable for ensuring the integrity and accuracy of the work, and read and approved the final manuscript.

Corresponding author

Correspondence to Luis E. Simental-Mendía.

Ethics declarations

Ethics approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rodríguez-Hernández, H., Simental-Mendía, L.E. The triglycerides and glucose index is highly associated with non-alcoholic fatty liver disease in overweight and obese women. Ir J Med Sci 192, 2741–2746 (2023). https://doi.org/10.1007/s11845-023-03335-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-023-03335-4

Keywords

Navigation